Carnitine and lipid profile in uremia

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Nutritional Science

Background:

• Patients undergoing hemodialysis often experience unfavorable alterations in their lipid profiles.
• Accelerated atherosclerosis is a significant concern in patients with end-stage renal disease requiring hemodialysis.

Purpose of the Study:

• To review the existing literature on L-carnitine supplementation in hemodialysis patients.
• To evaluate the impact of L-carnitine on lipid profiles and its potential role in mitigating accelerated atherosclerosis.

Main Methods:

• Systematic review of studies investigating L-carnitine supplementation in hemodialysis patients.
• Analysis of reported changes in plasma lipid levels (e.g., cholesterol, triglycerides) across different studies.
• Assessment of reported effects on the progression of atherosclerosis.

Main Results:

• Studies report highly dissimilar outcomes regarding L-carnitine's effect on lipid profiles.
• Some studies indicate favorable changes, while others show no effect or even a worsening of lipid parameters.
• Data on L-carnitine's influence on accelerated atherosclerosis progression remains inconclusive.

Conclusions:

• The suitability of L-carnitine supplementation for improving lipid profiles in hemodialysis patients is uncertain due to conflicting results.
• Further research is warranted to clarify the role of L-carnitine in managing dyslipidemia and atherosclerosis in this patient group.